Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Graham Pockley

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Medcomm|May 13, 2026
Development of CAR NK Cell Lines Selectively Targeting Cancer Cells Expressing Membrane Hsp70Khouloud Hachani, Mina Yazdi, Charlotte Carcopino, et al.
NPJ Breast Cancer|July 22, 2021
IL-1B drives opposing responses in primary tumours and bone metastases; harnessing combination therapies to improve outcome in breast cancerClaudia Tulotta, Diane V Lefley, Charlotte K Moore, et al.
BMC Gastroenterology|June 2, 2019
Autologous stem cell transplantation in refractory Crohn's disease - low intensity therapy evaluation (ASTIClite): study protocols for a multicentre, randomised controlled trial and observational follow up studyJohn A Snowden, Chris Hawkey, Daniel Hind, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2020
Targeted Natural Killer Cell-Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy: A Randomized Phase II Clinical TrialGabriele Multhoff, Sophie Seier, Stefan Stangl, et al.
The Lancet. Gastroenterology & Hepatology|February 10, 2024
Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): an open-label, multicentre, randomised controlled trialJames O Lindsay, Daniel Hind, Lizzie Swaby, et al.
Science Translational Medicine|June 5, 2020
Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemiaJayakumar Vadakekolathu, Mark D Minden, Tressa Hood, et al.
European Journal of Immunology|December 15, 2021
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)Andrea Cossarizza, Hyun-Dong Chang, Andreas Radbruch, et al.
European Journal of Immunology|October 13, 2017
Guidelines for the use of flow cytometry and cell sorting in immunological studiesAndrea Cossarizza, Hyun-Dong Chang, Andreas Radbruch, et al.
European Journal of Immunology|October 22, 2019
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)Andrea Cossarizza, Hyun-Dong Chang, Andreas Radbruch, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Medcomm|May 13, 2026
Development of CAR NK Cell Lines Selectively Targeting Cancer Cells Expressing Membrane Hsp70Khouloud Hachani, Mina Yazdi, Charlotte Carcopino, et al.
NPJ Breast Cancer|July 22, 2021
IL-1B drives opposing responses in primary tumours and bone metastases; harnessing combination therapies to improve outcome in breast cancerClaudia Tulotta, Diane V Lefley, Charlotte K Moore, et al.
BMC Gastroenterology|June 2, 2019
Autologous stem cell transplantation in refractory Crohn's disease - low intensity therapy evaluation (ASTIClite): study protocols for a multicentre, randomised controlled trial and observational follow up studyJohn A Snowden, Chris Hawkey, Daniel Hind, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2020
Targeted Natural Killer Cell-Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy: A Randomized Phase II Clinical TrialGabriele Multhoff, Sophie Seier, Stefan Stangl, et al.
The Lancet. Gastroenterology & Hepatology|February 10, 2024
Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): an open-label, multicentre, randomised controlled trialJames O Lindsay, Daniel Hind, Lizzie Swaby, et al.
Science Translational Medicine|June 5, 2020
Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemiaJayakumar Vadakekolathu, Mark D Minden, Tressa Hood, et al.
European Journal of Immunology|December 15, 2021
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)Andrea Cossarizza, Hyun-Dong Chang, Andreas Radbruch, et al.
European Journal of Immunology|October 13, 2017
Guidelines for the use of flow cytometry and cell sorting in immunological studiesAndrea Cossarizza, Hyun-Dong Chang, Andreas Radbruch, et al.
European Journal of Immunology|October 22, 2019
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)Andrea Cossarizza, Hyun-Dong Chang, Andreas Radbruch, et al.
Pageof 8